Overview
Michael Milligan is a Radiation Oncologist practicing medicine in Portsmouth, New Hampshire.
His clinical expertise encompasses Lung Cancer, Breast Cancer, Metastatic Brain Tumor, and Prostate Cancer.
He is actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
333 Borthwick Ave, Portsmouth, NH 03801
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Brigham And Women's Hospital
Brian Alexander is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Alexander is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Massachusetts General Hospital
Helen Shih is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Shih is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Meningioma, Brain Tumor, Astrocytoma, Acoustic Neuroma, and Tissue Biopsy.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Mak is board certified in Radiation Oncology.
Frequently Asked Questions about Dr. Michael Milligan
Is Dr. Michael Milligan a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Milligan is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael Milligan specialize in?
While Dr. Michael Milligan is a Radiation Oncology, they have specific expertise in Lung Cancer, Breast Cancer, and Metastatic Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Michael Milligan participate in research or clinical trials?
Yes. Dr. Michael Milligan has published 25 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Michael Milligan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael Milligan accept my insurance?
Dr. Michael Milligan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acoustic NeuromaDr. Milligan isExperienced. Learn about Acoustic Neuroma.
- AngiosarcomaDr. Milligan isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Milligan isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Milligan isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Milligan isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Milligan isExperienced. Learn about Breast Cancer.